Clark, Kelly

Fax: No facsimile telecopying (also known as "fax") telephone number is available for this contact
DMCC Person ID: 4278
EDRN Title: No title conferred
Specialty: None given

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

None Available.

Closed Protocols

No closed protocols.


Publication Name PubMed ID Journal
Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. 15082792 Mol. Cell. Biol.
Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer. 15735726 Oncogene
Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction. 21254049 Cancer
Do serum biomarkers really measure breast cancer? 19476629 BMC Cancer
Estrogen receptor alpha (ESR1) mutant A908G is not a common feature in benign and malignant proliferations of the breast. 15034868 Genes Chromosomes Cancer
Evaluation of expression based markers for the detection of breast cancer cells. 16319979 Breast Cancer Res. Treat.
Expression signatures of TP53 mutations in serous ovarian cancers. 20504346 BMC Cancer
Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. 16603642 Mol. Cancer Res.
Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. 21852960 PLoS Genet.
Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. 21852960 PLoS Genet.
High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer. 16432260 Nucleic Acids Res.
Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy. 19208741 Mol. Cancer Res.
Isogenic normal basal and luminal mammary epithelial isolated by a novel method show a differential response to ionizing radiation. 17409405 Cancer Res.
Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients. 20473856 Int. J. Cancer
Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. 19318476 Clin. Cancer Res.
Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care. 19224362 Breast Cancer Res. Treat.
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. 15897565 Clin. Cancer Res.
Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased. 21586622 Cancer Epidemiol. Biomarkers Prev.
Pooling of case specimens to create standard serum sets for screening cancer biomarkers. 17301268 Cancer Epidemiol. Biomarkers Prev.
Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers. 15598772 Cancer Epidemiol. Biomarkers Prev.
Role of eotaxin-1 signaling in ovarian cancer. 19351767 Clin. Cancer Res.
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer. 18474099 Breast Cancer Res.
TAFII70 isoform-specific growth suppression correlates with its ability to complex with the GADD45a protein. 15328371 Mol. Cancer Res.
The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy. 21501600 Biochem. Pharmacol.
The type III TGF-beta receptor suppresses breast cancer progression. 17160136 J. Clin. Invest.
Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues. 23274563 Gynecol. Oncol.
Yeast screens identify the RNA polymerase II CTD and SPT5 as relevant targets of BRCA1 interaction. 18197258 PLoS ONE

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Version 5.1.0